5 reports

  • PRESENTS CERENIS THERAPEUTICS' DYSLIPIDEMIA PORTFOLIO.
  • CERENIS THERAPEUTICS' DYSLIPIDEMIA PORTFOLIO ASSESSMENT, 2015

PLOS ONE; ##(##): ##-##.

  • Cholesterol
  • AstraZeneca PLC
  • Cerenis
  • Merck & Co., Inc.
  • The Medicines Company

Additional assays could be developed for the platform, including tuberculosis.

  • Cholesterol
  • Abaxis, Inc.
  • Alere Inc.
  • PTS DIAGNOSTICS
  • Roche Group

S##. and Rehabilitation; ##(##): ##-##.

  • Cholesterol
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Pfizer Inc.

The period saw the launch of the Genedrive®tuberculosis (TB) and associated antibiotic resistance test in India.

  • Cholesterol
  • Clinical Trial
  • Diagnostics
  • United States
  • GlobalData's company

JD-## acts as a cannabinoid receptor type ## (CB##) antagonist.

  • Analgesic
  • Cholesterol
  • Obesity
  • Research And Development
  • Jenrin Discovery, Inc.